This opportunity is for the sole-source acquisition of one Illumina MiSeq i100 Whole Genome Sequencing System for the FDA Irvine Medical Products Laboratory. The system is required for compatibility with existing validated workflows, consumables, software, and procedures. The procurement includes the system, components, software, delivery, installation, training, and manufacturer warranty support. No specific budget amount or performance timeline is mentioned in the description. The location for performance is the FDA Irvine Medical Products Laboratory.